Mycophenalate Mofetil

Were you looking for information about
 Mycophenolate Mofetil? Mycophenalate mofetil is a common misspelling of mycophenolate mofetil.
 
By making the immune system less active, mycophenolate mofetil (CellCept®) can help prevent organ rejection after a kidney, liver, or heart transplant. It comes in the form of a capsule, a tablet, an oral liquid suspension, and an intravenous (IV) injection.
 
Although most people tolerate this medicine well, side effects are possible and may include pain, swelling, and high blood pressure. You may not be able to use this drug if you have certain medical conditions, such as diabetes, kidney disease, or any kind of infection.
 
(For more information on this medicine, click Mycophenolate Mofetil. This full-length article offers a complete overview of this medication, including general dosing guidelines and what to discuss with your healthcare provider. You can also click any of the links in the box to the right for more specific information.)
Written by/reviewed by: Susan Lakey, PharmD, MPH, BCPP
Last reviewed by: Kristi Monson, PharmD